Related Experiment Videos
Late recurrence of a primitive neuro-ectodermal tumor.
R D Rao1, H I Robins, M P Mehta
1Department of Medicine, University of Wisconsin, Madison, USA.
Oncology
|September 28, 2001
Summary
Late primitive neuro-ectodermal tumor (PNET) recurrence is rare, typically occurring within 5 years. This case details a PNET recurrence 17 years post-therapy, discussing implications and treatment responses.
Area of Science:
- Neuro-oncology
- Pediatric Oncology
- Medical Genetics
Background:
- Primitive neuro-ectodermal tumors (PNETs) are rare malignant brain tumors.
- Most PNET recurrences occur within the first 2-5 years post-therapy.
- Late recurrences beyond 5 years are exceptionally uncommon.
Observation:
- A 31-year-old woman presented with a PNET recurrence 17 years after initial diagnosis and therapy.
- This represents a significantly delayed relapse compared to typical PNET recurrence patterns.
Findings:
- The case highlights the possibility of very late PNET recurrences, challenging established timelines.
- The patient's response to subsequent therapies, including temozolomide, was evaluated.
Implications:
- This case prompts re-evaluation of long-term surveillance strategies for PNET survivors.
- Understanding the biological mechanisms of late PNET recurrence may inform future treatment approaches.
- Further research into genetic factors could explain such rare late events.